Research study Program year 2025 Source: CMS Open Payments

0000000000000000000000000000000000000000000000000000000000000000214364

Research payments

$1,406,951

10 payments

Through program year 2025, $1,406,951 in research payments was reported against 0000000000000000000000000000000000000000000000000000000000000000214364, across 10 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$58,517	1
2021	Research	$1,134,124	7
2019	Research	$214,309	2

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $1,406,951 10 payments

Who received the money Research payments · program years 2019–2025

California Pacific Medical Center Organisation paid for research $1,348,433 9 payments
California Pacific Medical Center P Organisation paid for research $58,517 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Kevin Kim San Francisco, CA Named on 10 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.